Patents by Inventor Noboru Chida

Noboru Chida has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2,4-DIAMINOPYRIMIDINE COMPOUND
    Publication number: 20110159019
    Abstract: Provided is a compound which is useful as an active ingredient for a pharmaceutical having a PKC? inhibition activity, particularly a pharmaceutical composition for inhibiting acute rejection occurring in transplantation. The present inventors have conducted extensive studies on a compound having a PKC? inhibition activity, and as a result, they have found that a compound having a structure such as aralkyl and the like on an amino group at the 2-position and also having a structure such as an adamantylalkyl group and the like on an amino group at the 4-position of 2,4-diaminopyrimidine, or a salt thereof has an excellent PKC? inhibition activity, thereby completing the present invention. The 2,4-diaminopyrimidine compound of the present invention can be used as a PKC? inhibitor or an inhibitor of acute rejection occurring in transplantation.
    Type: Application
    Filed: August 31, 2009
    Publication date: June 30, 2011
    Inventors: Akira Tanaka, Koichiro Mukoyoshi, Shigeki Kunikawa, Yuji Takasuna, Jun Maeda, Noboru Chida, Shinya Nagashima
  • Immunosuppressive imidazole derivatives and their combination preparations with tacrolimus of cyclosporins
    Publication number: 20040092436
    Abstract: Present invention is relating to a new use of a compound possessing an inhibitory activity on the production of nitric oxide, for increasing an effect caused by IL-2 inhibitor.
    Type: Application
    Filed: November 7, 2003
    Publication date: May 13, 2004
    Applicant: Fujisawa Pharmaceutical Company, Ltd.
    Inventors: Fumihiko Sakai, Harumi Yamazaki, Noboru Chida, Osamu Nakayama, Yoshihiro Yokota
  • Immunosuppressive imidazole derivatives and their combination preparations with tacrolimus or cyclosporins
    Patent number: 6673807
    Abstract: Methods for increasing graft survival time comprising administering the combination of a compound that inhibits the production of nitric oxide and a compound that is a tricyclic macrolide, such as tacrolimus.
    Type: Grant
    Filed: December 1, 2000
    Date of Patent: January 6, 2004
    Assignee: Fujisawa Pharmaceutical Co., Ltd.
    Inventors: Fumihiko Sakai, Harumi Yamazaki, Noboru Chida, Osamu Nakayama, Yoshihiro Yokota